TY - JOUR
T1 - Ameliorative potential of Sterculia tragacantha aqueous extract on renal gene expression and biochemical parameters in streptozotocin-induced diabetic rats
AU - Ajiboye, Basiru Olaitan
AU - Oyinloye, Babatunji Emmanuel
AU - Essien, Precious Ekong
AU - Onikanni, Sunday Amos
AU - Ojo, Oluwafemi Adeleke
AU - Kappo, Abidemi Paul
N1 - Publisher Copyright:
© 2020, The Korean Society of Pharmaceutical Sciences and Technology.
PY - 2021/1
Y1 - 2021/1
N2 - Purpose: The ameliorative potential of aqueous leave extract of Sterculia tragacantha on renal gene expression and biochemical parameters in streptozotocin-induced diabetic rats were assessed. Methods: Forty albino rats (out of fifty) were intraperitoneally induced using 35 mg/kg of streptozotocin, and then grouped into normal control, diabetic control, diabetic animals received 150 and 300 mg/kg of aqueous extract of S. tragacantha leaves (AESTL) and diabetic animals placed on 200 mg/kg of metformin. This experiment lasted for two weeks, animals were sacrificed, and a series of biochemical indices were evaluated. Results: Diabetic rats receiving AESTL revealed a momentous decline in fasting blood glucose, urea, creatinine, uric acid, and alkaline phosphatase levels. Administration of AESTL to diabetic animals considerably improved the activities of SOD, CAT, GPx, GST, and GSH with a decline in MDA levels. Also, AESTL reversed abnormalities in mRNA gene expressions of IL-1β, TGF-1β, KIM-1, EPO and CASP 6 in diabetic rats placed on AESTL treatment. The excellent results of diabetic rats maintained on AESTL were supported by histological findings in this study. Conclusion: Hence, AESTL may have beneficial effects in controlling nephropathy associated with diabetes mellitus.
AB - Purpose: The ameliorative potential of aqueous leave extract of Sterculia tragacantha on renal gene expression and biochemical parameters in streptozotocin-induced diabetic rats were assessed. Methods: Forty albino rats (out of fifty) were intraperitoneally induced using 35 mg/kg of streptozotocin, and then grouped into normal control, diabetic control, diabetic animals received 150 and 300 mg/kg of aqueous extract of S. tragacantha leaves (AESTL) and diabetic animals placed on 200 mg/kg of metformin. This experiment lasted for two weeks, animals were sacrificed, and a series of biochemical indices were evaluated. Results: Diabetic rats receiving AESTL revealed a momentous decline in fasting blood glucose, urea, creatinine, uric acid, and alkaline phosphatase levels. Administration of AESTL to diabetic animals considerably improved the activities of SOD, CAT, GPx, GST, and GSH with a decline in MDA levels. Also, AESTL reversed abnormalities in mRNA gene expressions of IL-1β, TGF-1β, KIM-1, EPO and CASP 6 in diabetic rats placed on AESTL treatment. The excellent results of diabetic rats maintained on AESTL were supported by histological findings in this study. Conclusion: Hence, AESTL may have beneficial effects in controlling nephropathy associated with diabetes mellitus.
KW - Anti-nephropathy
KW - Diabetic
KW - Management
KW - mRNA gene expression
UR - http://www.scopus.com/inward/record.url?scp=85095597544&partnerID=8YFLogxK
U2 - 10.1007/s40005-020-00506-8
DO - 10.1007/s40005-020-00506-8
M3 - Article
AN - SCOPUS:85095597544
SN - 2093-5552
VL - 51
SP - 103
EP - 113
JO - Journal of Pharmaceutical Investigation
JF - Journal of Pharmaceutical Investigation
IS - 1
ER -